TETRAPHASE PHARMACEUTICALS INC Proceeds from Long-Term Debt Issued
TETRAPHASE PHARMACEUTICALS INC reported Proceeds from Long-Term Debt Issued of $18.75 million for the 93-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2016-02-25
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2013-12-31 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2013-09-30 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for the quarter ending 2013-06-30 was $0.00.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2013 was $3.00M, a 51.61% decline from fiscal 2012.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2012 was $6.20M, a 22.50% decline from fiscal 2011.
- TETRAPHASE PHARMACEUTICALS INC proceeds from issuance of long-term debt for fiscal 2011 was $8.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 81 month | Proceeds from Issuance of Long-term Debt 84 month | Proceeds from Issuance of Long-term Debt 87 month | Proceeds from Issuance of Long-term Debt 90 month | Proceeds from Issuance of Long-term Debt 93 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 | $18.75M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $3.00M 10-K · filed 2016-02-25 | $18.75M 10-K · filed 2014-03-06 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $3.00M 10-Q · filed 2014-11-10 | $18.75M 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $3.00M 10-Q · filed 2014-08-12 | $18.75M 10-Q · filed 2013-08-12 | ||||||
| 2013-03-31 | $3.00M 10-Q · filed 2014-05-12 | $18.75M 10-Q · filed 2013-05-13 | |||||||
| 2012-12-31 | $6.20M 10-K · filed 2015-03-06 | ||||||||
| 2011-12-31 | $8.00M 10-K · filed 2014-03-06 |